Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level.

Background: Equitable access to essential medicines of maintained efficacy, safety, quality, and cost-effectiveness must be ensured by a well-functioning health system. This study aims to identify the determinants of patients' access to medicines at the primary health care (PHC) level from the perspectives of various (internal and external) stakeholders of the pharmaceutical system.

Methods: The study employed both quantitative and qualitative components.